Tryg - Transactions in connection with share buyback programme Feb 9, 2026 04:29AM

On 22 January 2026, Tryg A/S (“Tryg”) announced that the Board of Directors had decided to initiate a share buyback programme of up to DKK 1.0 billion. The share buyback programme is executed in accordance with EU Market Abuse Regulation, EU Regulation no. 596/2014 of 16 April 2014 and the provisions of Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (the “Safe Harbour Regulation”). The share buyback programme will end no later than 13 May 2026.

... (continue reading...)


Hanna Inget appointed to Luotea’s Executive Management Team to lead the company’s growth and customer experience Feb 9, 2026 04:30AM

 Luotea has appointed Hanna Inget (M.Sc. Econ.) as the company’s Chief Commercial Officer and a member of the Executive Management Team. She will take up her position on 1 March 2026. In her role, Inget will be responsible for Luotea’s growth, commercial operations, and customer experience.

The appointment supports Luotea’s strategy, which focuses on achieving annual growth of 4–5%, strengthening customer experience, and developing data-driven, technology-enabled... (continue reading...)


Notification of managers’ transactions Feb 9, 2026 04:28AM

ANNOUNCEMENT NO. 301

9 February 2026

Notification of managers’ transactions

ChemoMetec A/S has received the enclosed notification pursuant to Article 19 of EU Regulation no. 596/2014 of transactions related to shares in ChemoMetec A/S made by persons discharging managerial responsibilities in ChemoMetec A/S and/or persons closely associated with them.

See the transactions of the Chair of ChemoMetec’s Board of Directors Niels Thestrup in the attached PDF document.

... (continue reading...)


Disclosure of trading in own shares from February 2, 2026 to February 6, 2026 Feb 9, 2026 04:15AM

Head Office : 4 allée de l'Arche, 92400 Courbevoie, FranceTel : + 33 (0) 1 78 15 00 00 – www.nexans.coma French Société Anonyme with a share capital of € 43,744,779 – R.C.S. Nanterre 393 525 852 – Id VAT FR 74 393 525 852            Disclosure of trading in own shares         From February 02, 2026 to February 06, 2026        Issuer : Nexans          Category : treasury shares                      Pursuant to applicable law on share buybacks, Nexans declares the... (continue reading...)
Form 8.3 - Inspecs Group Plc Feb 9, 2026 04:09AM

Downing LLPLEI: 213800G3X76VBG9SB50409 February 2026Form 8.3 re. Inspecs Group Plc

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)

1.        KEY INFORMATION

(a)   Full name of discloser:Downing LLP(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):Client funds managed by Downing LLP(c)   Name of... (continue reading...)

More Globe Newswire

View Older Stories

Feb 9, 2026 04:08AM CSG to Become a Partner of the Prestigious Munich Security Conference for the First Time This Year
Feb 9, 2026 04:00AM Festi hf.: Buyback program week 6
Feb 9, 2026 04:00AM OPEN Health Announces Strategic Leadership Appointments to Strengthen Enterprise Growth and Decision Quality
Feb 9, 2026 04:00AM Sampo plans to issue new Restricted Tier 1 notes
Feb 9, 2026 04:00AM SalMar - Invitation to presentation of the fourth quarter 2025 results
Feb 9, 2026 04:00AM WorldWiDE EdTech Awards 2026 Winners Announced
Feb 9, 2026 03:55AM Kaldalón hf.: Routine Announcement Regarding Share Buybacks Pursuant to Buyback Program
Feb 9, 2026 03:51AM "Discover Shanghai" Tourism Guide Super Competition Concludes, Showcasing How Public Co-creation Fuels Sustainable Cultural and Tourism Growth
Feb 9, 2026 03:51AM "Discover Shanghai" Tourism Guide Super Competition Concludes, Showcasing How Public Co-creation Fuels Sustainable Cultural and Tourism Growth
Feb 9, 2026 03:50AM Preliminary data on early redemptions (prepayments)
Feb 9, 2026 03:30AM Strong clinical data for Breye Therapeutics’ lead oral asset danegaptide presented at Angiogenesis, Exudation and Degeneration 2026 symposium
Feb 9, 2026 03:30AM Alm. Brand A/S – Weekly report on share buybacks
Feb 9, 2026 03:24AM OVHcloud unveils Bare Metal 2026 line-up powered by the latest AMD processors
Feb 9, 2026 03:20AM Bavarian Nordic – Completion of Share Buy-Back Program
Feb 9, 2026 03:14AM Borregaard ASA: Shares for employees 2026
Feb 9, 2026 03:02AM Columbus – Weekly report on share buyback
Feb 9, 2026 03:00AM Aptean Unveils Aptean Intelligence as a Service, Delivering Industry‑Ready AI Agents That Drive Real Operational Results
Feb 9, 2026 03:00AM Municipality Finance issues a USD 100 million tap under its MTN programme
Feb 9, 2026 03:00AM Municipality Finance issues USD 20 million notes under its MTN programme
Feb 9, 2026 03:00AM Schroders and Apollo to deliver next generation investment solutions in ambitious multi-channel partnership
Feb 9, 2026 02:57AM Share buyback programme – week 6
Feb 9, 2026 02:56AM 8/2026・Trifork Group: Weekly report on share buyback
Feb 9, 2026 02:48AM Banco Comercial Português, S.A. informs about Bank Millennium (Poland) preliminary unaudited results in 2025
Feb 9, 2026 02:32AM ESOP – shares for key employees
Feb 9, 2026 02:30AM Sovereign‑ready cloud and AI innovation set to scale for European enterprises with Capgemini solutions on the AWS Sovereign Cloud
Feb 9, 2026 02:30AM LEADING EDGE MATERIALS AND ASCENSION EARTH RESOURCES TEAM UP ON HEAVY RARE EARTHS RECOVERY FROM NORRA KÄRR EUDIALYTE
Feb 9, 2026 02:27AM Best THC Gummies for Pain Relief in 2026: Budpop Ranked No.1 by Kstate Collegian
Feb 9, 2026 02:25AM Prepayments (CK93) - Totalkredit A/S
Feb 9, 2026 02:25AM Prepayments (CK93) - Nykredit Realkredit A/S
Feb 9, 2026 02:16AM CMB.TECH FLEET UPDATE
Feb 9, 2026 02:11AM BioPorto A/S Appoints Chief Financial Officer
Feb 9, 2026 02:10AM TRUNNANO Breaks Through Key Technology for Reaction Sintered Silicon Carbide Ceramics
Feb 9, 2026 02:00AM Falcon Oil & Gas Ltd. - Notice of Special Meeting of Shareholders and Management Information Circular
Feb 9, 2026 02:00AM FTI Consulting Strengthens Transactional Capabilities With Senior M&A and Due Diligence Hire
Feb 9, 2026 02:00AM Avacta appoints Francis Wilson as Chief Scientific Officer
Feb 9, 2026 02:00AM Pulsar Helium Reports Pressurized Gas Encounter at Jetstream #6 at the Topaz Helium Project, USA
Feb 9, 2026 02:00AM FTI Consulting Strengthens Transactional Capabilities With Senior M&A and Due Diligence Hire
Feb 9, 2026 02:00AM Memo Therapeutics AG Enters into a Collaboration and Option Agreement with CSL for Development of Recombinant Polyclonal IgG Technology
Feb 9, 2026 02:00AM Falcon Oil & Gas Ltd. - Notice of Special Meeting of Shareholders and Management Information Circular
Feb 9, 2026 02:00AM NBPE Announces Transaction in Own Shares
Feb 9, 2026 02:00AM Net Asset Value
Feb 9, 2026 02:00AM OSB GROUP PLC - Transaction in Own Shares
Feb 9, 2026 02:00AM Transaction in Own Shares
Feb 9, 2026 01:57AM Airwheel Announces Expanded Global Deployment of AI-Enabled Rideable Smart Electric Cabin Suitcase
Feb 9, 2026 01:43AM Share repurchase programme: Transactions of week 6 2026
Feb 9, 2026 01:15AM Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
Feb 9, 2026 01:00AM Aktsiaselts Infortar own share acquisition transactions
Feb 9, 2026 01:00AM Press Release: Sanofi’s rilzabrutinib designated breakthrough therapy in the US and orphan drug in Japan for the treatment of warm autoimmune hemolytic anemia
Feb 9, 2026 01:00AM WISeKey’s WISe.Art and GMA Once Again Revolutionize the Future of Art and Technology in an Extraordinary Event in Venice
Feb 9, 2026 01:00AM Start of Day Message
View Older Stories